This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A good retirement plan is essential for financial security in your later years. Explore the key features that make a retirement plan effective.
19,612 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A high-profile kidnapping tied to crypto ransom ends in an arrest abroad, underscoring risks for the crypto ecosystem...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
A Maryland homeowner stands accused of calling ICE on workers fixing her roof, raising serious questions about legal ...
Morgan Stanley halves Lucid's price target to $5, keeping an Underweight rating as production stoppages and a leaders...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
A fast-moving shift in AI could turn cyber threats into a global financial crisis if firms don’t act. This article br...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
This article dives into exagen (XGN) 2026 earnings, unpacking Q1 results, business momentum, and the path to full-yea...
Susquehanna lifts Plug Power’s price target to $3.75 as the Quantum Leap cost-cutting program shows early momentum. C...